Bulletin
Investor Alert

Iovance Biotherapeutics Inc.

NAS: IOVA

GO
/marketstate/country/us

After Hours

/zigman2/quotes/206632254/composite

$

7.07

Change

+0.05 +0.71%

Volume

Volume 751,289

May 27, 2022, 7:59 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/206632254/composite

Previous close

$ 15.12

$ 7.02

Change

-8.10 -53.57%

Day low

Day high

$6.75

$7.91

Open
Open: 7.80

52 week low

52 week high

$6.75

$28.00

Open

Market cap

$1.10B

Average volume

2.97M

P/E ratio

N/A

Rev. per Employee

N/A

EPS

-2.30

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/iova

MarketWatch News on IOVA

  1. Iovance Biotherapeutics stock price target cut to $20 from $29 at Truist

    7:14 a.m. May 27, 2022

    - Tomi Kilgore

  2. Iovance Biotherapeutics stock price target cut to $13 from $26 at Stifel Nicolaus

    6:52 a.m. May 27, 2022

    - Tomi Kilgore

  3. Iovance Biotherapeutics upgraded to buy from hold at Stifel Nicolaus

    7:55 a.m. Jan. 28, 2022

    - Tomi Kilgore

  4. Iovance Reports Cancer Drug Data That Looks Positive

    11:09 a.m. June 29, 2021

    - Barron's Online

  5. Biotech M&A Has Been Slow This Year. Why It Might Get Busier.

    8:32 a.m. May 21, 2021

    - Barron's Online

  6. Iovance Stock Falls Almost 40% on Double Dose of Bad News

    8:46 a.m. May 20, 2021

    - Barron's Online

  7. Iovance Biotherapeutics stock price target cut to $30 from $55 at Mizuho

    6:54 a.m. May 20, 2021

    - Tomi Kilgore

  8. Iovance Biotherapeutics started at buy with $50 stock price target at Truist

    8:15 a.m. May 3, 2021

    - Tomi Kilgore

  9. Iovance Biotherapeutics started at buy with $61 stock price target at Mizuho

    7:34 a.m. April 22, 2020

    - Tomi Kilgore

  10. The massive decline in the S&P 500 is probably already overdone

    2:21 p.m. Feb. 27, 2020

    - Lawrence G. McMillan

  11. Iovance Biotherapeutics started at buy with $27 stock price target at Stifel Nicolaus

    7:49 a.m. Oct. 1, 2019

    - Tomi Kilgore

  12. Link to Amazon Could Boost Semtech Shares

    9:30 p.m. Sept. 27, 2019

    - Barron's Online

  13. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/iova

Other News on IOVA

  1. Why Iovance Biotherapeutics Was Halved Today

    1:08 p.m. May 27, 2022

    - Motley Fool

  2. AVDL, SIGA, PSHG and IOVA among mid-day movers

    12:56 p.m. May 27, 2022

    - Seeking Alpha

  3. Iovance sheds half of market cap after melanoma data

    11:37 a.m. May 27, 2022

    - Seeking Alpha

  4. Iovance slips after trial data for melanoma candidate

    4:22 p.m. May 26, 2022

    - Seeking Alpha

  5. Why Cellectis' Shares Rose 22.7% This Week

    7:35 p.m. May 20, 2022

    - Motley Fool

  6. Seagen: Brewing Blockbusters

    8:38 a.m. May 9, 2022

    - Seeking Alpha

  7. NovoCure: A Stalwart With More Upsides

    6:38 a.m. May 9, 2022

    - Seeking Alpha

  8. 10-Q: IOVANCE BIOTHERAPEUTICS, INC.

    5:29 p.m. May 5, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  9. Iovance Biotherapeutics Q1 2022 Earnings Preview

    5:35 p.m. May 4, 2022

    - Seeking Alpha

  10. IDNA: A Long Term Prospect, Slowly Overcoming The Bearish Rally

    2:21 p.m. April 29, 2022

    - Seeking Alpha

  11. Clovis: Shifting Toward Nuclear Medicine

    12:33 p.m. April 25, 2022

    - Seeking Alpha

  12. Alpine: Rest Before Rallying Again

    12:08 p.m. April 25, 2022

    - Seeking Alpha

  13. Iovance: Onward To Approval

    8:15 a.m. April 20, 2022

    - Seeking Alpha

  14. Iovance (IOVA) Stock Rallies 33% in a Month: Here's Why

    3:17 p.m. April 8, 2022

    - Zacks.com

  15. Loading more headlines...
/news/pressrelease/company/us/iova

Press Releases on IOVA

  1. Loading more headlines...

Rates »

Link to MarketWatch's Slice.